Psychology
-
In a first-of-its-kind study, researchers pitted mindfulness meditation against a common antidepressant in a trial on patients with anxiety. The findings reveal an eight-week mindfulness program was as effective at reducing anxiety as drug treatment.
-
A study has found an old antipsychotic drug blocks a signaling pathway that has been linked to chronic pain. The surprising findings not only point to novel treatments for pain but reveal an unexpected association between chronic pain and lung cancer.
-
In a first-of-its-kind pilot study, scientists have implanted a device designed to disrupt brain signals associated with binge-eating food cravings into two human volunteers, pointing to a future where implants control a variety of impulsive behaviors.
-
A study has reported results from the first ever placebo-controlled trial testing psilocybin-assisted psychotherapy for alcohol use disorder, but the findings inadvertently raise major questions about the veracity of clinical trials for psychedelic drugs.
-
We’re all maybe a bit surly after a sleepless night, but a new study suggests our levels of day-to-day selfishness can be directly related to how well rested we are, and these findings could have implications on both individual and societal levels.
-
The first data has been announced from a Phase 2 trial testing LSD as treatment for anxiety. The results indicate one to two LSD sessions can generate rapid and sustained reductions to anxiety but larger trials are needed to validate these findings.
-
New research published in Nature Communications has found boy and girls can be vulnerable to the negative effects of social media use at different times during their adolescence, with massive variations between different individuals.
-
A new study offers the first investigation into mental health issues in non-hospitalized COVID-19 patients up to 16 months after initial infection. The findings reveal COVID-19 led to a higher risk of long-term depression depending on initial severity.
-
A study has reported the results of the first modern clinical investigation to compare the acute effects of psychedelics LSD and psilocybin. The study reveals little subjective difference between the two drugs beyond LSD lasting longer than psilocybin.
-
When conducting studies on how people react to different emotions, actual human faces may not express those emotions the same way each time, while photos just aren't as impactful. That's why scientists have developed a robotic head to do the job.
-
New research has offered valuable insights into the long-term effects of psilocybin-assisted psychotherapy for depression. The study reports more than half the original cohort were still in remission 12 months after the acute psychedelic treatment.
-
A unique placebo-controlled clinical trial has investigated the popular phenomenon of psychedelic microdosing. The trial found tiny doses of psilocybin resulted in no changes to signs of anxiety or depression compared to placebo.
Load More